Business

Practice Management

Malpractice Consult

Health Law & Policy

Clinical

All Clinical

Benign Conditions

Bladder Cancer

Female Urology

Genitourinary Cancers

Hormone Therapy

Kidney Cancer

Kidney Stones

Men's Health

Next-Generation Imaging

Pediatrics

Prostate Cancer

Sexual Dysfunction

Urologic Surgery

Media

Case-Based Peer Perspectives

Investigator Perspectives 

Medical World News

Podcasts

Rapid Readouts

Urology Medical Perspectives

UTv Videos

UroView

Viewpoints

Virtual Tumor Board

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

CME/CE

Resources

Begin Your Journey: Tackling Burnout

Interactive Tools

Job Board

Partners

Subscribe

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times | News & Insights for Urologists & Health Professionals

Facebook

Twitter

LinkedIn

Spotlight

Genomic Testing

OAB and Incontinence

1rem

View

Use of Targeted Imaging Modalities in Prostate Cancer: Key Challenges and Considerations  

Videos

Expert insight from David M. Albala, MD, on the evolving landscape of imaging modalities in prostate cancer and how it has impacted treatment pathways.

Join David Albala, MD, as he explores the use of advanced imaging techniques in prostate cancer diagnosis and management, highlighting PSMA-PET scans and their pivotal role in modern prostate cancer care.

An Overview of PSMA-PET Scans and Prostate Cancer Imaging

Explore the transformative journey of prostate cancer imaging techniques, from conventional methods to cutting-edge PET scans like F-18 PSMA, and how FDA approvals have shaped their adoption.

Advancements in Prostate Cancer Imaging: The Evolution of PET Scans 

Insight into advancements in prostate cancer imaging using PSMA agents like gallium and F-18, their unique characteristics, and the considerations in choosing the right radiotracer for accurate detection.

Prostate Cancer Imaging: PSMA Agents and Radiotracer Options 

Overview of hurdles and advancements in utilizing advanced imaging techniques for prostate cancer diagnosis, including agent availability, scheduling, facility preferences, and reimbursement.

Challenges and Progress in Advanced Imaging for Prostate Cancer

David Albala, MD, discusses how starting October 1st, CMS will reimburse imaging centers directly, simplifying the process and removing reimbursement concerns for physicians ordering radiotracer tests.

CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

The significance of patient convenience, evolving imaging techniques, and recent breakthroughs in prostate cancer care, with a focus on the role of PSA-PET scanning in directing patient treatment.

Prostate Cancer Imaging and Care in 2023: Best Practices

David Albala, MD, shares closing advice on using PSMA-PET scans in prostate cancer management and making informed patient selection decisions based on guidelines and practical insights.

Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient Selection

Prostate Cancer Imaging and Care in 2023: Best Practices

EP: 1.An Overview of PSMA-PET Scans and Prostate Cancer Imaging

EP: 2.Advancements in Prostate Cancer Imaging: The Evolution of PET Scans

EP: 3.Prostate Cancer Imaging: PSMA Agents and Radiotracer Options

EP: 4.Challenges and Progress in Advanced Imaging for Prostate Cancer

EP: 5.CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

EP: 6.Prostate Cancer Imaging and Care in 2023: Best Practices

EP: 7.Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient Selection